CIPLA
Back to Income Statement
|
CIPLA Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹51.05 | ₹34.71 | ₹31.19 | ₹29.82 | ₹19.18 |
What is the latest Earnings Per Share (EPS) of CIPLA ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2025 | ₹51.05 |
| Mar2024 | ₹34.71 |
| Mar2023 | ₹31.19 |
| Mar2022 | ₹29.82 |
| Mar2021 | ₹19.18 |
How is Earnings Per Share (EPS) of CIPLA Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2025 | ₹51.05 | 47.08 | |
| Mar2024 | ₹34.71 | 11.29 | |
| Mar2023 | ₹31.19 | 4.59 | |
| Mar2022 | ₹29.82 | 55.47 | |
| Mar2021 | ₹19.18 | - | |
Compare Earnings Per Share (EPS) of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹118,435.6 Cr | -3.5% | -1.5% | -2.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,073.0 Cr | -0% | -3.2% | -5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,657.0 Cr | 4% | 5.2% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,121.0 Cr | 2.4% | 4.5% | 18.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,944.0 Cr | -3.2% | -3.3% | -10.6% | Stock Analytics | |
| MANKIND PHARMA | ₹90,806.8 Cr | 0.3% | 2.4% | -22.7% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | -3.5% |
-1.5% |
-2.5% |
| SENSEX | -2.6% |
-1.3% |
7.2% |
You may also like the below Video Courses